These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Physical and dissolution characteristics and bio-availability of five brands of digoxin tablets. Fletcher S; Summers RS S Afr Med J; 1980 Apr; 57(14):530-3. PubMed ID: 7368019 [TBL] [Abstract][Full Text] [Related]
7. Recognition of variable bioavailability as an international problem: a review of the earlier studies. Munro-Faure AD; Fowle AS; Fox J; Johnson BF; Lader S Postgrad Med J; 1974 Nov; 50 Suppl 6():14-8. PubMed ID: 4459882 [No Abstract] [Full Text] [Related]
8. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin. Binnion PF J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789 [TBL] [Abstract][Full Text] [Related]
10. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model. Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304 [TBL] [Abstract][Full Text] [Related]
11. Digoxin preparations: variation in biological availability. McCredie RM; Cody DV; Mackie AM; Ng KK; Worner FL; Chow M; Milstead G Med J Aust; 1973 Nov; 2(20):922-5. PubMed ID: 4765886 [No Abstract] [Full Text] [Related]
12. The biological availability of very rapidly dissolving digoxin tablets. Shaw TR; Raymond K; Greenwood H Postgrad Med J; 1974 Nov; 50 Suppl 6():55-9. PubMed ID: 4459890 [No Abstract] [Full Text] [Related]
13. Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets. Shaw TR; Howard MR; Hamer J Br Heart J; 1974 Jan; 36(1):85-9. PubMed ID: 4818143 [No Abstract] [Full Text] [Related]
15. [Effect of formulation of enterosoluable preparations on the physiologic availability of the active principle. 1: Effect on the rate of liberation of acetylsalicylic acid from enteric tablets on absorption characteristics in vivo]. Delporte JP; Jaminet F J Pharm Belg; 1975; 30(2):99-113. PubMed ID: 1206458 [No Abstract] [Full Text] [Related]
16. Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate. Nyberg L; Andersson KE; Bertler A Acta Pharm Suec; 1974 Nov; 11(5):471-92. PubMed ID: 4440505 [No Abstract] [Full Text] [Related]
17. Digoxin solution in capsules (Lanoxicaps). Med Lett Drugs Ther; 1983 Dec; 25(650):111-2. PubMed ID: 6656690 [No Abstract] [Full Text] [Related]
18. Digoxin absorption from tablets and elixir. The effect of radiation-induced malabsorption. Jusko WJ; Conti DR; Molson A; Kuritzky P; Giller J; Schultz R JAMA; 1974 Dec; 230(11):1554-5. PubMed ID: 4479663 [No Abstract] [Full Text] [Related]
19. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests]. Bodem G; Ochs H; Hahn E; Dengler HJ Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012 [TBL] [Abstract][Full Text] [Related]
20. Digoxin tablets--a review of the bioavailability problems. Sim SK Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]